Melika Lotfi

1.3k citations
3 papers · 736 indexed · 1 hit paper · h-index 3
Topics
SARS-CoV-2 and COVID-19 Research (3 papers)COVID-19 Clinical Research Studies (2 papers)Long-Term Effects of COVID-19 (2 papers)
Partner nations
IranIndiaSouth Africa

In The Last Decade

Melika Lotfi

3 papers receiving 714 citations

Hit Papers

COVID-19: Transmission, prevention, and potential therape...20202026202220242020200400600

Peers

Melika Lotfi
Comparison fields: 5 of 131
  • Infectious Diseases 316
  • Neurology 128
  • Clinical Psychology 112
  • Modeling and Simulation 110
  • Oncology 67
Replace Xuejiao Liao with:
Xuejiao Liao China
Carmen Huber Canada
Shen Qian China
Katherine Simbaña‐Rivera Ecuador
Lenin Gómez‐Barreno Ecuador
Bo Pan China
Haypheng Te Cambodia
Yi‐Ying Lin Taiwan
Farzane Behnezhad Iran
Ye Guo China
Melika Lotfi relative to Xuejiao Liao China Xuejiao Liao's profile →
Citations per field
00.5×1.5×
Xuejiao Liao · 1×
Citations per year

Countries citing papers authored by Melika Lotfi

Since Specialization
Citations

This map shows the geographic impact of Melika Lotfi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Melika Lotfi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Melika Lotfi more than expected).

Fields of papers citing papers by Melika Lotfi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Melika Lotfi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Melika Lotfi. The network helps show where Melika Lotfi may publish in the future.

Co-authorship network of co-authors of Melika Lotfi

This figure shows the co-authorship network connecting the top 25 collaborators of Melika Lotfi. A scholar is included among the top collaborators of Melika Lotfi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Melika Lotfi. Melika Lotfi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

3 of 3 papers shown
#WorkIndexed citations
1 46
2 84
3
COVID-19: Transmission, prevention, and potential therapeutic opportunitiesbreakdown →
606

About Melika Lotfi

Melika Lotfi is a scholar working on Infectious Diseases, Neurology and Public Health, Environmental and Occupational Health, having authored 3 papers that have together received 736 indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (3 papers), COVID-19 Clinical Research Studies (2 papers) and Long-Term Effects of COVID-19 (2 papers). The work is most often cited by research in Modeling and Simulation (110 citations), Infectious Diseases (316 citations) and General Dentistry (25 citations). Melika Lotfi has collaborated with scholars based in Iran, India and South Africa. Frequent co-authors include Nima Rezaei and Michael R. Hamblin. Their work appears in journals such as Clinica Chimica Acta, Biomedicine & Pharmacotherapy and Journal of Medical Virology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026